BRKR
Bruker Corporation · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website bruker.com
- Employees(FY) 8525
- ISIN US1167941087
Performance
-5.52%
1W
-18.49%
1M
+4.3%
3M
+26.67%
6M
+0.36%
YTD
-4.2%
1Y
Profile
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Investment Analysis Report: BRKR
Overview
In this investment analysis report, we will delve into the financial statements of BRKR, a company operating in the Health Technology sector specializing in Medical Specialties. We will analyze the company's valuation, financial health, earnings and revenue growth, profitability, operating margin, operat...
Technical Analysis of BRKR 2024-05-03
Overview:
In the last 5 trading days, BRKR stock has shown a significant decline in price from $81.26 to $70.04, accompanied by a notable increase in trading volume. The technical indicators across trend, momentum, volatility, and volume categories provide insights into the stock's potential future price movement.
Trend Analysis:
- Moving Average...
Recent News & Updates
- 2024-05-07 14:45
Bruker's NanoString Secures Patent Case Win in Germany(MT Newswires)
- 2024-05-07 14:04
- 2024-05-07 06:57
Bruker First Quarter 2024 Earnings: Misses Expectations(Simply Wall St.)
- 2024-05-07 02:04
- 2024-05-06 16:05
Bruker Completes Asset Acquisition of NanoString Business(Business Wire)
- 2024-05-06 09:35
- 2024-05-06 04:05
- 2024-05-05 21:35
- 2024-05-03 15:31
- 2024-05-03 12:22
- 2024-05-03 03:12
- 2024-05-03 00:22
- 2024-05-02 10:30
- 2024-05-02 10:08
- 2024-05-02 09:40
- 2024-05-02 08:34
- 2024-05-02 08:25
- 2024-05-02 07:27
Bruker: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-02 07:00
- 2024-05-02 07:00
Bruker Reports First Quarter 2024 Financial Results(Business Wire)
- 2024-05-01 22:30
- 2024-05-01 20:25
- 2024-05-01 19:00
- 2024-05-01 19:00
Bruker Reports First Quarter 2024 Financial Results(Businesswire)
- 2024-05-01 11:41
- 2024-05-01 09:15
- 2024-05-01 07:46
- 2024-04-30 21:15
- 2024-04-30 08:15
- 2024-04-29 20:15
Page 1 of 8
previousnext